Announced Tue, 14 Jul · 12:13 IST
Reg 74(5) certificate filing for Q1 FY27 — no re-materialisation requests
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
KMS Medisurgi submitted the Regulation 74(5) certificate for quarter ended 30 June 2026. Registrar KFIN Technologies confirmed the regulation does not apply as the entire shareholding is already held in demat form, and no member requested re-materialisation during the quarter. Signed by Managing Director Siddharth Kanakia.
Likely market impact
Routine compliance filing with no material impact on shareholders or stock price.